MedCap AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,108	1,807	1,587	1,124	926.3
Other Revenue	-	0.6	1.6	0.2	-
Revenue	2,108	1,807	1,589	1,124	926.3
Revenue Growth (YoY)	16.64%	13.74%	41.37%	21.34%	11.87%
Cost of Revenue	871.9	749.6	660.7	446.8	357.7
Gross Profit	1,236	1,058	928.3	677.2	568.6
Selling, General & Admin	791.5	698.5	601.1	443.5	384.6
Amortization of Goodwill & Intangibles	85.7	-	-	-	-
Other Operating Expenses	9.5	3	7.9	3.3	4.7
Operating Expenses	954.4	816.8	712.1	528.1	464.8
Operating Income	281.7	240.9	216.2	149.1	103.8
Interest Expense	-24.8	-18.5	-15.6	-16.4	-9.4
Interest & Investment Income	17.6	8.3	7	2.3	0.4
Earnings From Equity Investments	-	-	-	-	1.3
Currency Exchange Gain (Loss)	-	5	14.7	2.8	1.7
Other Non Operating Income (Expenses)	21.2	0.2	0.1	0.1	-
EBT Excluding Unusual Items	295.7	235.9	222.4	137.9	97.8
Gain (Loss) on Sale of Assets	-	-	-	20	4
Asset Writedown	-	-0.1	-0.9	-6.5	-
Other Unusual Items	-6.7	25.7	-	0.6	15.1
Pretax Income	289	261.6	222.3	152	117
Income Tax Expense	68.3	52.3	49.8	34	18.9
Earnings From Continuing Operations	220.7	209.3	172.5	118	98.1
Net Income to Company	220.7	209.3	172.5	118	98.1
Minority Interest in Earnings	-0.9	-1.9	-0.3	-0.4	-1.6
Net Income	219.8	207.4	172.2	117.6	96.5
Net Income to Common	219.8	207.4	172.2	117.6	96.5
Net Income Growth	5.98%	20.44%	46.43%	21.87%	58.46%
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15
Shares Change (YoY)	1.20%	-0.21%	0.33%	0.04%	3.10%
EPS (Basic)	14.67	14.00	11.63	7.94	6.52
EPS (Diluted)	14.67	14.00	11.60	7.90	6.50
EPS Growth	4.80%	20.66%	46.84%	21.54%	53.18%
Free Cash Flow	317	318.3	205.9	59.2	71
Free Cash Flow Per Share	21.13	21.47	13.86	4.00	4.80
Gross Margin	58.64%	58.52%	58.42%	60.25%	61.38%
Operating Margin	13.36%	13.33%	13.61%	13.26%	11.21%
Profit Margin	10.43%	11.48%	10.84%	10.46%	10.42%
Free Cash Flow Margin	15.04%	17.61%	12.96%	5.27%	7.66%
EBITDA	435	304.9	268.3	188.6	141.1
EBITDA Margin	20.64%	16.87%	16.89%	16.78%	15.23%
D&A For EBITDA	153.3	64	52.1	39.5	37.3
EBIT	281.7	240.9	216.2	149.1	103.8
EBIT Margin	13.36%	13.33%	13.61%	13.26%	11.21%
Effective Tax Rate	23.63%	19.99%	22.40%	22.37%	16.15%
Revenue as Reported	2,129	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.